Regenerative Medical Technology Group Inc.: cashflow_financing
| Value | {"amount": 62370, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-03-31 |
| Status | current |
| Entity | Regenerative Medical Technology Group Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/beb3cc75-7e3d-45b8-984d-03864b6544cb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-19-009466Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001760026/cashflow-financing/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/beb3cc75-7e3d-45b8-984d-03864b6544cb
History
- no predecessors — first report